Immune profile diversity is achieved with synthetic TLR4 agonists combined with the RG1-VLP vaccine in mice.
Matthews RL, Khan N, Beckman B, Sharma S, Dietz Z, Picking WD, Izmirlian G, Sanders C, Stocks SM, Difilippantonio S, Kirnbauer R, Roden RB, Pinto LA, Shoemaker RH, Ernst RK, Marshall JD.
Matthews RL, et al. Among authors: pinto la.
Vaccine. 2025 Jan 12;44:126577. doi: 10.1016/j.vaccine.2024.126577. Epub 2024 Dec 3.
Vaccine. 2025.
PMID: 39632208
Free article.